ATE167522T1 - Monoklonale antikörper gegen mögliche hcv- hüllregionen und methoden diese zu benutzen - Google Patents
Monoklonale antikörper gegen mögliche hcv- hüllregionen und methoden diese zu benutzenInfo
- Publication number
- ATE167522T1 ATE167522T1 AT92906219T AT92906219T ATE167522T1 AT E167522 T1 ATE167522 T1 AT E167522T1 AT 92906219 T AT92906219 T AT 92906219T AT 92906219 T AT92906219 T AT 92906219T AT E167522 T1 ATE167522 T1 AT E167522T1
- Authority
- AT
- Austria
- Prior art keywords
- monoclonal antibodies
- methods
- antibodies against
- against possible
- hcv envelope
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—RNA viruses
- C07K16/116—Togaviridae (F); Matonaviridae (F); Flaviviridae (F)
- C07K16/118—Hepatitis C virus; GB virus C [GBV-C]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material
- C12N5/12—Fused cells, e.g. hybridomas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
- C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Virology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- General Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US64847591A | 1991-01-31 | 1991-01-31 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE167522T1 true ATE167522T1 (de) | 1998-07-15 |
Family
ID=24600936
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT92906219T ATE167522T1 (de) | 1991-01-31 | 1992-01-30 | Monoklonale antikörper gegen mögliche hcv- hüllregionen und methoden diese zu benutzen |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP0569537B1 (de) |
| JP (1) | JP3483555B2 (de) |
| KR (1) | KR930703361A (de) |
| AT (1) | ATE167522T1 (de) |
| AU (1) | AU662517B2 (de) |
| CA (1) | CA2101534C (de) |
| DE (1) | DE69225960T2 (de) |
| DK (1) | DK0569537T3 (de) |
| ES (1) | ES2118129T3 (de) |
| WO (1) | WO1992013892A1 (de) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR0185426B1 (ko) * | 1991-06-24 | 1999-04-01 | 로버트 피. 블랙버언 | 씨형 간염 바이러스 폴리펩티드 |
| JP3217600B2 (ja) * | 1994-07-12 | 2001-10-09 | 株式会社先端生命科学研究所 | 非a非b型肝炎ウイルス関連抗原のイムノアッセイ、それに使用するモノクローナル抗体、およびこの抗体を産生するハイブリドーマ |
| WO1996004385A2 (en) | 1994-07-29 | 1996-02-15 | Innogenetics N.V. | Purified hepatitis c virus envelope proteins for diagnostic and therapeutic use |
| EP0947525A1 (de) * | 1998-03-27 | 1999-10-06 | Innogenetics N.V. | Epitope in der viralen Hüllproteine und spezifische Antikörper gegen diese Epitope: Verwendung für die detektion von viralantigene im empfängergewebe |
| CA2380777C (en) * | 1999-07-28 | 2011-01-04 | Chiron Corporation | Hepatitis c viral antigen immunoassay detection systems |
| US6815160B1 (en) | 1999-07-28 | 2004-11-09 | Chiron Corporation | Hepatitis C viral antigen immunoassay detection systems |
| US8551484B2 (en) | 2007-02-21 | 2013-10-08 | University Of Massachusetts | Human antibodies against hepatitis C virus (HCV) and uses thereof |
| AU2008280057A1 (en) | 2007-07-25 | 2009-01-29 | Japan As Represented By Director-General Of National Institute Of Infectious Diseases | Antibody having inhibitory activity on infection with hepatitis C virus (HCV), and use thereof |
| JP5608087B2 (ja) | 2008-09-30 | 2014-10-15 | 東レ株式会社 | C型肝炎ウイルスのエンベロープタンパク質2に結合する抗体及びそれを用いたc型肝炎ウイルスの遺伝子型の同定方法 |
| US8592559B2 (en) | 2009-10-30 | 2013-11-26 | Toray Industries, Inc. | Antibody having activity of inhibiting hepatitis C virus (HCV) infection and use thereof |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1982002774A1 (en) * | 1981-02-11 | 1982-08-19 | Baxter Travenol Lab | Non-a,non-b hepatitis virus |
| BR8807310A (pt) * | 1987-11-18 | 1990-03-13 | Chiron Corp | Polinucleotidio,polinucleotidio recombinante,vetor recombinante,celula hospedeira,sistema de expressao recombinante,celula transformada,polipeptidio,hcv,preparacao de polipeptidio,polipeptidio de hcv,polipeptidio purificado,polipeptidio recombinante,polipeptidio de fusao,anticorpo monoclonal,preparacao purificada de anticorpos policlonais,particula,sonda de polinucleotidio,kit anticorpo para epetopo de hcv,metodo para producao de polipeptidio,metodo para deteccao de acidos nucleicos de hcv,imunoensaio para detectar antigeno de hcv,imunoensaio para detectar anticorpos dirigidos contra antigeno de hcv,vacina para tratamento de infeccao de hcv,celula,celula infectada com hcv,metodo para producao de anticorpos para hcv e metodo para isolar cdna derivado do genoma de um agente infeccioso nao identificado |
| HU225068B1 (en) * | 1989-03-17 | 2006-05-29 | Chiron Corp | Process for producing diagnostics and vaccine of nanbh |
| AU638304B2 (en) * | 1989-12-22 | 1993-06-24 | Abbott Laboratories | Hepatitis c assay |
| AU7672991A (en) * | 1990-04-03 | 1991-10-30 | Southwest Foundation For Biomedical Research | Purified hcv and hcv proteins and peptides |
| CA2049679C (en) * | 1990-08-24 | 2005-06-21 | Sushil G. Devare | Hepatitis c assay utilizing recombinant antigens |
| ES2161682T3 (es) * | 1990-11-03 | 2001-12-16 | Dade Behring Marburg Gmbh | Peptidos especificos a hcv, agentes adecuados para ellos y su utilizacion. |
| KR930702507A (ko) * | 1990-11-07 | 1993-09-09 | 챨스 엠. 브록 | C형 간염 바이러스에 대한 모노클로날 항체 및 이의 사용 방법 |
-
1992
- 1992-01-30 DE DE69225960T patent/DE69225960T2/de not_active Expired - Lifetime
- 1992-01-30 DK DK92906219T patent/DK0569537T3/da active
- 1992-01-30 AT AT92906219T patent/ATE167522T1/de not_active IP Right Cessation
- 1992-01-30 JP JP50626492A patent/JP3483555B2/ja not_active Expired - Lifetime
- 1992-01-30 WO PCT/US1992/000687 patent/WO1992013892A1/en not_active Ceased
- 1992-01-30 CA CA002101534A patent/CA2101534C/en not_active Expired - Lifetime
- 1992-01-30 AU AU13627/92A patent/AU662517B2/en not_active Expired - Fee Related
- 1992-01-30 EP EP92906219A patent/EP0569537B1/de not_active Expired - Lifetime
- 1992-01-30 ES ES92906219T patent/ES2118129T3/es not_active Expired - Lifetime
- 1992-01-30 KR KR1019930702258A patent/KR930703361A/ko not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| CA2101534A1 (en) | 1992-08-01 |
| JPH06505389A (ja) | 1994-06-23 |
| AU662517B2 (en) | 1995-09-07 |
| EP0569537A4 (en) | 1994-10-05 |
| DE69225960D1 (de) | 1998-07-23 |
| EP0569537A1 (de) | 1993-11-18 |
| HK1012838A1 (en) | 1999-08-06 |
| CA2101534C (en) | 2004-01-20 |
| AU1362792A (en) | 1992-09-07 |
| WO1992013892A1 (en) | 1992-08-20 |
| ES2118129T3 (es) | 1998-09-16 |
| DK0569537T3 (da) | 1999-04-06 |
| KR930703361A (ko) | 1993-11-29 |
| EP0569537B1 (de) | 1998-06-17 |
| DE69225960T2 (de) | 1999-01-21 |
| JP3483555B2 (ja) | 2004-01-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0603307A4 (de) | Monoklonale antikörper gegen putative hcv-e2/ns1-proteine und verfahren zu ihrer verwendung. | |
| ATE239756T1 (de) | Humaner monoklonaler antikörper gegen hepatitis b virus oberflächen antigen (hbvsag) | |
| FI942369A0 (fi) | Hepatitis-C-virustesti | |
| NZ237666A (en) | Hiv envelope (env) polypeptides, antibodies and compositions for treating aids | |
| PT1190257E (pt) | Deteccao precoce dos flavivirus, utilizando a glicoproteina ns1 | |
| ATE382683T1 (de) | Monoklonales antikörper gegen das hcv kernantigen | |
| NO169844C (no) | Htlv-iii (env)-peptider | |
| ATE336512T1 (de) | Epitope in der viralen hüllproteine und spezifische antikörper gegen diese epitope: verwendung für die detektion von hcv viralantigene im empfängergewebe | |
| DE69225960D1 (de) | Monoklonale antikörper gegen mögliche hcv-hüllregionen und methoden diese zu benutzen | |
| DE69532062D1 (de) | Immuntests von nicht-A, nicht-B Hepatitisvirus-verwandten Antigenen, monoklonale Antikörper und diese synthetisierende Hybridome | |
| DE69224134D1 (de) | Monoklonale Antikörper gegen Hepatitis-C-Virus | |
| DK1002092T3 (da) | Mimotoper af hypervariabel region 1 af E2-glycoproteinet fra HCV og anvendelser deraf | |
| ATE174060T1 (de) | Monoklonale antikörper gegen mutmassliche hepatitis c-virus ns5-proteine und ihre anwendungsmethoden | |
| ATE178096T1 (de) | Monoklonale antikörper gegen den hepatitis c- virus und verfahren diese zu benutzen | |
| BR0204612C1 (pt) | anticorpos monoclonais antinúcleo de hcv | |
| NO924137L (no) | Monoklonale anti-igm-antistoffer, deres fremstilling og anvendelse, og hybridomas for fremstilling av de samme |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |